PortfoliosLab logoPortfoliosLab logo
CIB0.DE vs. ESIH.DE
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

CIB0.DE vs. ESIH.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in VanEck Bionic Engineering UCITS ETF A (CIB0.DE) and iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc) (ESIH.DE). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

CIB0.DE vs. ESIH.DE - Yearly Performance Comparison


2026 (YTD)2025202420232022
CIB0.DE
VanEck Bionic Engineering UCITS ETF A
-9.78%-10.00%5.16%2.09%-1.65%
ESIH.DE
iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc)
-0.15%7.95%4.09%7.63%-1.51%

Returns By Period

In the year-to-date period, CIB0.DE achieves a -9.78% return, which is significantly lower than ESIH.DE's -0.15% return.


CIB0.DE

1D
1.37%
1M
-8.85%
YTD
-9.78%
6M
-3.29%
1Y
-11.01%
3Y*
-6.52%
5Y*
10Y*

ESIH.DE

1D
1.57%
1M
-4.69%
YTD
-0.15%
6M
5.41%
1Y
5.30%
3Y*
5.20%
5Y*
7.36%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


CIB0.DE vs. ESIH.DE - Expense Ratio Comparison

CIB0.DE has a 0.55% expense ratio, which is higher than ESIH.DE's 0.18% expense ratio.


Return for Risk

CIB0.DE vs. ESIH.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CIB0.DE
CIB0.DE Risk / Return Rank: 22
Overall Rank
CIB0.DE Sharpe Ratio Rank: 33
Sharpe Ratio Rank
CIB0.DE Sortino Ratio Rank: 33
Sortino Ratio Rank
CIB0.DE Omega Ratio Rank: 33
Omega Ratio Rank
CIB0.DE Calmar Ratio Rank: 22
Calmar Ratio Rank
CIB0.DE Martin Ratio Rank: 00
Martin Ratio Rank

ESIH.DE
ESIH.DE Risk / Return Rank: 2020
Overall Rank
ESIH.DE Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
ESIH.DE Sortino Ratio Rank: 1818
Sortino Ratio Rank
ESIH.DE Omega Ratio Rank: 1818
Omega Ratio Rank
ESIH.DE Calmar Ratio Rank: 2323
Calmar Ratio Rank
ESIH.DE Martin Ratio Rank: 2222
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CIB0.DE vs. ESIH.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for VanEck Bionic Engineering UCITS ETF A (CIB0.DE) and iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc) (ESIH.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CIB0.DEESIH.DEDifference

Sharpe ratio

Return per unit of total volatility

-0.56

0.28

-0.84

Sortino ratio

Return per unit of downside risk

-0.68

0.50

-1.18

Omega ratio

Gain probability vs. loss probability

0.92

1.07

-0.15

Calmar ratio

Return relative to maximum drawdown

-0.70

0.58

-1.29

Martin ratio

Return relative to average drawdown

-1.80

1.64

-3.44

CIB0.DE vs. ESIH.DE - Sharpe Ratio Comparison

The current CIB0.DE Sharpe Ratio is -0.56, which is lower than the ESIH.DE Sharpe Ratio of 0.28. The chart below compares the historical Sharpe Ratios of CIB0.DE and ESIH.DE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


CIB0.DEESIH.DEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.56

0.28

-0.84

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.47

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.25

0.45

-0.70

Correlation

The correlation between CIB0.DE and ESIH.DE is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

CIB0.DE vs. ESIH.DE - Dividend Comparison

Neither CIB0.DE nor ESIH.DE has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

CIB0.DE vs. ESIH.DE - Drawdown Comparison

The maximum CIB0.DE drawdown since its inception was -26.12%, roughly equal to the maximum ESIH.DE drawdown of -26.69%. Use the drawdown chart below to compare losses from any high point for CIB0.DE and ESIH.DE.


Loading graphics...

Drawdown Indicators


CIB0.DEESIH.DEDifference

Max Drawdown

Largest peak-to-trough decline

-26.12%

-26.69%

+0.57%

Max Drawdown (1Y)

Largest decline over 1 year

-15.52%

-13.44%

-2.08%

Max Drawdown (5Y)

Largest decline over 5 years

-26.69%

Current Drawdown

Current decline from peak

-24.58%

-8.97%

-15.61%

Average Drawdown

Average peak-to-trough decline

-9.86%

-7.14%

-2.72%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.06%

4.55%

+1.51%

Volatility

CIB0.DE vs. ESIH.DE - Volatility Comparison

VanEck Bionic Engineering UCITS ETF A (CIB0.DE) and iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc) (ESIH.DE) have volatilities of 5.01% and 5.06%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


CIB0.DEESIH.DEDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.01%

5.06%

-0.05%

Volatility (6M)

Calculated over the trailing 6-month period

12.42%

11.69%

+0.73%

Volatility (1Y)

Calculated over the trailing 1-year period

19.46%

19.22%

+0.24%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

17.80%

15.59%

+2.21%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

17.80%

15.45%

+2.35%